These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 1081055)

  • 21. Immunological studies in childhood scleroderma.
    Stögmann W; Sandhofer M; Fritz J
    Eur J Pediatr; 1977 Feb; 124(3):223-30. PubMed ID: 300058
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Immunologic studies in sclerodermia].
    Jablonska S; Chorzelski T
    Allerg Immunol (Leipz); 1972; 18(3):187-90. PubMed ID: 4269352
    [No Abstract]   [Full Text] [Related]  

  • 23. Autoantibodies in childhood scleroderma.
    Bernstein RM; Pereira RS; Holden AJ; Black CM; Howard A; Ansell BM
    Ann Rheum Dis; 1985 Aug; 44(8):503-6. PubMed ID: 3875322
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Localized scleroderma and hemiatrophy in association with antibodies to double-stranded DNA.
    Adebajo AO; Crisp AJ; Nicholls A; Hazleman BL
    Postgrad Med J; 1992 Mar; 68(797):216-8. PubMed ID: 1589383
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Profile of antibodies against nuclear and polynucleotide antigens in diffuse scleroderma].
    Zitnan D; Cebecauer L; Rovenský J; Lukác J
    Cas Lek Cesk; 1982 Nov; 122(45):1392-7. PubMed ID: 6196115
    [No Abstract]   [Full Text] [Related]  

  • 26. Anti-agalactosyl immunoglobulin G antibodies in localized scleroderma.
    Mimra Y; Ihn H; Jinnin M; Asano Y; Yamane K; Yazawa N; Tamaki K
    Int J Dermatol; 2005 Oct; 44(10):817-20. PubMed ID: 16207181
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Demonstration of antinuclear antibodies in the epidermis of patients with progressive systemic sclerosis, generalized lupus erythematosus and dermatomyositis].
    Lamas Robles C; Mejía Arreguín S; Orozco Medina JH; González Mendoza A
    Rev Invest Clin; 1984; 36(2):115-9. PubMed ID: 6385174
    [No Abstract]   [Full Text] [Related]  

  • 28. [DNA antibody determination in diffuse connective-tissue disease (author's transl)].
    Kerl H; Sandhofer M; Klein G; Altmann H
    Dtsch Med Wochenschr; 1974 Aug; 99(32):1626-7. PubMed ID: 4602107
    [No Abstract]   [Full Text] [Related]  

  • 29. [Immunologic findings in progressive scleroderma--diagnostic and nosologic significance].
    Sönnichsen N; Brenke A; Barthelmes H; Albrecht-Nebe H; Diezel W
    Dermatol Monatsschr; 1983 Jun; 169(6):385-93. PubMed ID: 6603989
    [No Abstract]   [Full Text] [Related]  

  • 30. [Immunogenetic studies of familial occurrence of progressive systemic scleroderma and circumscribed scleroderma].
    Holzmann H; Schlieter A; Altmeyer P; Kühnl P
    Hautarzt; 1992 Sep; 43(9):548-53. PubMed ID: 1399599
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antibodies eluted from lymphoid cell membrane. Occurrence in certain varieties of scleroderma.
    Cormane RH; Hamerlinck F; Nunzi E
    Arch Dermatol; 1979 Jun; 115(6):709-12. PubMed ID: 453872
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antinucleosome antibody is a major autoantibody in localized scleroderma.
    Sato S; Kodera M; Hasegawa M; Fujimoto M; Takehara K
    Br J Dermatol; 2004 Dec; 151(6):1182-8. PubMed ID: 15606513
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunochemical characterization of the anti-RNA antibodies found in scleroderma and systemic lupus erythematosus. II. Reactivity with hsa-coupled, uridine-containing, monophosphoric ribodinucleotides.
    Alarcón-Segovia D; Fishbein E; Estrada-Parra S; García-Ortigoza E
    Immunology; 1976 Mar; 30(3):413-8. PubMed ID: 1082854
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The value of humoral immune phenomena in children and adolescents with circumscribed scleroderma].
    Albrecht-Nebe H; Stojanow K; Ziegler H; Eggert W; Barthelmes H
    Kinderarztl Prax; 1989 Jul; 57(7):315-26. PubMed ID: 2796119
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anti-U3 snRNP antibodies in localised scleroderma.
    Yimane K; Ihn H; Kubo M; Asano Y; Yazawa N; Tamaki K
    Ann Rheum Dis; 2001 Dec; 60(12):1157-8. PubMed ID: 11760725
    [No Abstract]   [Full Text] [Related]  

  • 36. [Indications of the systemic character of circumscript scleroderma in children and adolescents].
    Albrecht-Nebe H; Eggert W; Ziegler H; Barthelmes H; Wolf S
    Dermatol Monatsschr; 1987; 173(3):123-30. PubMed ID: 3496247
    [No Abstract]   [Full Text] [Related]  

  • 37. Antinuclear antibodies in children with localized scleroderma.
    Rosenberg AM; Uziel Y; Krafchik BR; Hauta SA; Prokopchuk PA; Silverman ED; Laxer RM
    J Rheumatol; 1995 Dec; 22(12):2337-43. PubMed ID: 8835572
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Serum antinuclear antibodies (in patients with visceral erythematodes, rheumatoid arthritis, progressive systemic sclerosis and discoid erythematodes)].
    Horvat Z
    Acta Med Iugosl; 1970; 24(3):229-40. PubMed ID: 4928076
    [No Abstract]   [Full Text] [Related]  

  • 39. Chromosome studies in scleroderma with consideration of anticentromere antibody status and assessment of possible in vitro clastogenic activity.
    Powell FC; Schroeter AL; Winkelmann RK; Dewald GW
    Acta Derm Venereol; 1986; 66(5):414-8. PubMed ID: 2431579
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical relevance of immunologic findings in scleroderma.
    Jablonska S; Blaszczyk M; Chorzelski TP; Jarzabek-Chorzelska M; Kumar V; Beutner EH
    Clin Dermatol; 1992; 10(4):407-21. PubMed ID: 1303806
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.